Summary
This review examines the Cancer Dependency Map, a comprehensive resource mapping genes required for cancer cell survival. The authors discuss the resource's current scope, methodological foundations in genome-wide CRISPR screening, and its emerging applications in identifying actionable therapeutic targets and understanding tumour biology. The work highlights how systematic dependency profiling may inform precision oncology and drug development.
Regional applicability
The Cancer Dependency Map is an internationally accessible resource; UK cancer researchers and pharmaceutical developers can leverage these data to prioritise therapeutic targets. However, the resource is primarily a research tool rather than a clinical intervention, and UK applicability depends on integration with NHS-relevant genomic and treatment infrastructure.
Key measures
Gene essentiality screens, CRISPR-based functional genomics, dependency patterns across cancer cell lines and tumour types
Outcomes reported
The paper reviews the Cancer Dependency Map resource, which systematically identifies genes essential for cancer cell survival across diverse tumour types. It synthesises current knowledge on how this resource informs drug discovery and personalised cancer treatment strategies.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.